NCT01248689

Brief Summary

One important goal in anesthetic management during ocular surgery is to provide adequate control of intraocular pressure (IOP). An increase in IOP may be catastrophic in patients with glaucoma or a penetrating open-eye injury. Accurate assessment of IOP is particularly important in infants and children with definite or suspected glaucoma undergoing examination under anesthesia. Anesthetic regimens in this surgical field commonly consist of short-acting anesthetic agents, such as sevoflurane. Sevoflurane is known to reduce the IOP. During pediatric ocular surgery, the inspired sevoflurane concentration varies continuously and may have an impact over the IOP that could affect the conduct of surgery. In this study the investigators wish to evaluate whether variations in sevoflurane concentration do affect the IOP.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 25, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2011

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

November 25, 2010

Status Verified

November 1, 2010

Enrollment Period

2 months

First QC Date

November 17, 2010

Last Update Submit

November 23, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • IOP

    IOP will be measured in both eyes, after induction of anesthesia and before the onset of surgery

    first hour of anesthesia

Study Arms (3)

concentration profile 1

ACTIVE COMPARATOR

IOP will be measured under this order of sevoflurane concentrations: 7%, 5%, 2%, 0.5%

Other: concentration profile 1

concentration profile 2

ACTIVE COMPARATOR

IOP will be measured under this order of sevoflurane concentrations: 7%, 2%, 5%, 0.5%

Other: concentration profile 2

concentration profile 3

ACTIVE COMPARATOR

IOP will be measured under this order of sevoflurane concentrations: 7%, 0.5%, 5%, 2%

Other: concentration profile 3

Interventions

IOP will be measured under this order of sevoflurane concentrations: 7%, 5%, 2%, 0.5%

Also known as: IOP measurements 1
concentration profile 1

IOP will be measured under this order of sevoflurane concentrations: 7%, 2%, 5%, 0.5%

Also known as: IOP measurements 2
concentration profile 2

IOP will be measured under this order of sevoflurane concentrations: 7%, 0.5%, 5%, 2%

Also known as: IOP measurements 3
concentration profile 3

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • children with healthy eyes, undergoing elective surgery for strabismus correction or tear duct probing and irrigation.

You may not qualify if:

  • children with adverse reaction or contraindication (of any other reason) to sevoflurane or remifentanil, and patients with pre-existing intra-ocular ophthalmic disease, or infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel-Aviv Sourasky Medical Center

Tel Aviv, 64239, Israel

Location

Related Publications (1)

  • Artru AA, Momota Y. Trabecular outflow facility and formation rate of aqueous humor during anesthesia with sevoflurane-nitrous oxide or sevoflurane-remifentanil in rabbits. Anesth Analg. 1999 Apr;88(4):781-6. doi: 10.1097/00000539-199904000-00019.

    PMID: 10195524BACKGROUND

Study Officials

  • Idit Matot, MD

    Tel-Aviv Sourasky Medical Center

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

November 17, 2010

First Posted

November 25, 2010

Study Start

February 1, 2011

Primary Completion

April 1, 2011

Study Completion

June 1, 2011

Last Updated

November 25, 2010

Record last verified: 2010-11

Locations